Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Percheron Therapeutics Appoints Michael Baker As Chief Executive Officer
PRIVATEAug 10, 2026•about 2 hours ago
Position
Chief Executive Officer
Company
Percheron Therapeutics Ltd
Michael Baker
BiotechnologyHealth CareTherapeutics
Description
Percheron Therapeutics has appointed Dr. Michael Baker as its new Chief Executive Officer. The transition comes as the company prepares to advance its lead oncology asset, HMBD-002, into a new clinical trial in the second half of 2026.
Company Information
Company
Percheron Therapeutics Ltd
About
Percheron Therapeutics is a biotechnology company focused on advancing oncology treatments. The company is preparing to advance its lead oncology asset, HMBD-002, into clinical trials. It has a commitment to drug development and engagement with the investment community.
Predictive Intelligence
Strategic
ML-powered predictions for Percheron Therapeutics Ltd's next move